Ascendis Pharma AS (ASND): ASCENDIS PHARMA A/S is a Danish-based b...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Ascendis Pharma AS (ASND)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	800
Posts	50861
Boards Moderated	2
Alias Born	12/12/2004

Re: None

Wednesday, 08/25/2021 5:17:30 PM

Wednesday, August 25, 2021 5:17:30 PM

ASCENDIS PHARMA A/S is a Danish-based biopharmaceutical company, which is involved in manufacture products for rare diseases. The Company utilizes its TransCon technologies for treatment, which can be applied to existing drug therapies, including proteins, peptides and small molecules, to create prodrugs. The Company is headquartered in Copenhagen, Denmark with offices in Heidelberg, Germany and Palo Alto, California.

New York Yankees and Duke Basketball

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent ASND News

Ascendis Pharma Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/02/2024 08:01:00 PM
Ascendis Pharma to Report First Quarter 2024 Financial Results and Provide Business Update on May 2, 2024 • GlobeNewswire Inc. • 04/25/2024 08:46:31 PM
United Kingdom’s MHRA Approves YORVIPATH® (palopegteriparatide) in Great Britain for the Treatment of Adults with Chronic Hypoparathyroidism • GlobeNewswire Inc. • 04/24/2024 12:30:00 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/07/2024 04:31:51 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 02:39:29 AM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 01:14:23 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 01:04:35 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 12:37:04 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 08:17:38 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 08:07:39 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 07:54:21 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 07:36:16 PM
Ascendis Pharma to Participate in the Leerink Partners Global Biopharma Conference 2024 • GlobeNewswire Inc. • 03/04/2024 01:30:00 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 04:00:18 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/29/2024 10:13:04 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/28/2024 09:49:51 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/27/2024 10:45:25 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/21/2024 08:17:44 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/16/2024 10:16:27 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/16/2024 10:15:40 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/16/2024 10:14:38 PM
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/14/2024 09:07:08 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/14/2024 04:40:46 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 02:17:03 PM

More ASND News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow